Medicare Analysis of EUA Outpatient Ambulatory Therapies Concludes Severe COVID-19 was Avoidable in 16%

Analysis Did not Consider AAPS Home Treatment Guide, Multidrug Protocols Launched in 2020 PETER MCCULLOUGH, MD FEB 3 The medical research community has had blinders on from the very beginning of the pandemic. Review papers and outcomes analysis have ignored the Association of American Physicians and Surgeons Home Treatment Guide published in October, 2020, featuring the McCullough Protocol. Additional protocols from FLCCC, Zelenko, and Raoult used similar principles but did not have the backing of a chartered, established medical society. Yet, the medical orthodoxy has refused to this day to acknowledge any of these protocols existed, were utilized, or resulted in patients not requiring Emergency Use Authorized (EUA) drugs and avoiding hospitalization and death. Wilcock et al, analyzed Medicare fee-for-service claims data and found that from 2021 forward, 23% of patients received acute COVID-19 ambulatory therapy. They concluded that 16% of severe cases could have been avoided. I have testified in the US Senate that two thirds of all American hospitalizations and deaths could have been avoided with full implementation of the McCullough Protocol as soon as it was initially published in The American Journal of Medicine, August 6, 2020, and certainly by October, 2020 with the widely disseminated AAPS Home Treatment Guide. The Wilcock paper is important because the authors point to a preventable fraction. We can only conclude that the proportion of hospitalization and deaths must have been enormous, potentially 85% if we would have had a global “home treatment first” for high-risk patients with their first case of COVID-19. www.aapsonline.org We we should never wait for the government to provide EUA drugs in a pandemic. As Wilcock and colleagues found, these drugs come too late, are poorly utilized, and may not be optimally used in combination with other drugs, so the population benefit is modest. Only early empiric multidrug therapy has the potential for a large, life-saving nationwide impact because its used immediately, leverages signals of benefit and acceptable safety, and is commercially available at the outset of the next pandemic. Share Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Upgrade to paid Please subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth. Peter A. McCullough, MD, MPH President, McCullough Foundation www.mcculloughfnd.org Wilcock AD, Kissler S, Mehrotra A, McGarry BE, Sommers BD, Grabowski DC, Grad YH, Barnett ML. Clinical Risk and Outpatient Therapy Utilization for COVID-19 in the Medicare Population. JAMA Health Forum. 2024 Jan 5;5(1):e235044. doi: 10.1001/jamahealthforum.2023.5044. PMID: 38277170; PMCID: PMC10818223. McCullough PA, Kelly RJ, Ruocco G, Lerma E, Tumlin J, Wheelan KR, Katz N, Lepor NE, Vijay K, Carter H, Singh B, McCullough SP, Bhambi BK, Palazzuoli A, De Ferrari GM, Milligan GP, Safder T, Tecson KM, Wang DD, McKinnon JE, O'Neill WW, Zervos M, Risch HA. Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. Am J Med. 2021 Jan;134(1):16-22. doi: 10.1016/j.amjmed.2020.07.003. Epub 2020 Aug 7. PMID: 32771461; PMCID: PMC7410805. You're currently a free subscriber to Courageous Discourse™ with Dr. Peter McCullough & John Leake. For the full experience, upgrade your subscription. Upgrade to paid SHARE LIKE COMMENT RESTACK © 2024 Peter McCullough MD MPH 548 Market Street PMB 72296, San Francisco, CA 94104 Unsubscribe Get the appStart writing

Laura-Lynn Tyler Thompson with Dr. McCullough Breaking Through Canadian Censorship

US Congressional Hearing, Analysis of Fauci Testimony, Vaccine Deaths, Disease X, all Trickling Through to Public PETER MCCULLOUGH, MD JAN 24 Nowhere is the importance of independent media more paramount than Canada. Laura-Lynn Tyler Thompson has been a beacon of light to conservative Canadians who have been seeking the truth through the veils of the government false narrative. From her website: “Inspirational and comedic speaker, Laura-Lynn Tyler Thompson is the former co-host of The 700 Club Canada, and author of “Relentless Redemption”. Having been a keynote speaker at events with over 10,000 in attendance, her career has spanned many years in the entertainment industry; she has had the privilege of speaking with many influential men and women from Hollywood and beyond. She now hosts Laura-Lynn Live, an online-daily broadcast, bringing attention to current news and politics at this epic hour! Known as one of the most courageous women speaking out against the leftist agenda and woke culture, she believes it’s time to rise with courage, or sink with cowardice.” Please watch this interview update for Canada on the January 9, 2024 US House Select Committee interrogation of Dr. Anthony Fauci followed by January 12 testimony from Drs. McCullough, Cole, and Milhoan on COVID-19 serious adverse events including death. We cover Disease X and much more. You can feel Thompson’s frustration as she puts cracks in the dam and wakes up Canada to the nightmare of the mass vaccination debacle. Share Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Upgrade to paid Please subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth. Peter A. McCullough, MD, MPH President, McCullough Foundation www.mcculloughfnd.org Courageous Discourse™ with Dr. Peter McCullough & John Leake © 2024 Peter McCullough MD MPH 548 Market Street PMB 72296, San Francisco, CA 94104 Unsubscribe

COVID-19, Peter A. McCullough, MD, MPH

 https://www.youtube.com/watch?v=dz0d6C2lpGE

https://www.youtube.com/watch?v=LZhtLRUGa3A

https://substack.com/@starfirecodes?utm_source=substack&utm_medium=email

COVID-19 Vaccination Cripples Senior Marathon Runner Into Wheelchair

Former CEO Devastated with Motor Neuropathy after 3 Shots--Agrees to Empiric Trial of McCullough Protocol Base Spike Detoxification

PETER MCCULLOUGH, MD DEC 2 By Peter A. McCullough, MD, MPH The World Health Organization as a layperson explanation of Guillain-Barré Syndrome (GBS) which is appropriate as more people are affected with this condition after SARS-CoV-2 infection and the ill-advised COVID-19 vaccines. “Symptoms typically last a few weeks, with most individuals recovering without long-term, severe neurological complications. The first symptoms of Guillain-Barré syndrome include weakness or tingling sensations. They usually start in the legs and can spread to the arms and face. For some people, these symptoms can lead to paralysis of the legs, arms, or muscles in the face. In approximately one third of people, the chest muscles are affected, making it hard to breathe. The ability to speak and swallow may become affected in severe cases of Guillain-Barré syndrome. These cases are considered life-threatening, and affected individuals should be treated in intensive-care units. Most people recover fully from even the most severe cases of Guillain-Barré syndrome, although some continue to experience weakness. Even in the best of settings, a small number of Guillain-Barré syndrome patients die from complications, which can include paralysis of the muscles that control breathing, blood infection, lung clots, or cardiac arrest.” Mr. Rod Shears is a 77 year-old former CEO and super fit marathon runner in the UK. He lives about 15 minutes outside of central London. Please listen to the description of what happened to him in 2021 after two AstraZeneca adenoviral COVID-19 shots and then a Pfizer mRNA booster. His syndrome is not classic for GBS because it is a dominant demyelinating motor neuropathy. This video is important, because Rod is in a wheelchair and obviously devastated with his vaccine injury. He has never heard of McCullough Protocol Base Spike Detoxification. As you will see, he has agreed to try the protocol and check in with Courageous discourse at 3, 6, 9, and 12 months to report on his condition. In the absence of large randomized trials, we must rely on clinical judgement and empirical evidence to understand safety and treatment effect. Let’s hope for the best for Mr. Shears.

To try the products that Rod will use, go to the Courageous Discourse Wellness Company page to get your FREE annual membership and PROMO code COURAGE discounts.